190 related articles for article (PubMed ID: 12050369)
1. Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes.
Gierynska M; Kumaraguru U; Eo SK; Lee S; Krieg A; Rouse BT
J Virol; 2002 Jul; 76(13):6568-76. PubMed ID: 12050369
[TBL] [Abstract][Full Text] [Related]
2. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection.
Kumaraguru U; Gierynska M; Norman S; Bruce BD; Rouse BT
J Virol; 2002 Jan; 76(1):136-41. PubMed ID: 11739679
[TBL] [Abstract][Full Text] [Related]
3. Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8
Lopes PP; Todorov G; Pham TT; Nesburn AB; Bahraoui E; BenMohamed L
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437976
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
[TBL] [Abstract][Full Text] [Related]
5. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.
Toka FN; Suvas S; Rouse BT
J Virol; 2004 Dec; 78(23):13082-9. PubMed ID: 15542660
[TBL] [Abstract][Full Text] [Related]
6. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
Gmyrek GB; Filiberti A; Montgomery M; Chitrakar A; Royer DJ; Carr DJJ
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999018
[TBL] [Abstract][Full Text] [Related]
7. Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection.
Nicoli F; Gallerani E; Skarlis C; Sicurella M; Cafaro A; Ensoli B; Caputo A; Marconi PC; Gavioli R
Vaccine; 2016 Apr; 34(19):2216-24. PubMed ID: 27002499
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
9. An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.
Pack CD; Gierynska M; Rouse BT
Hum Vaccin; 2008; 4(5):360-4. PubMed ID: 18382144
[TBL] [Abstract][Full Text] [Related]
10. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
[TBL] [Abstract][Full Text] [Related]
11. The early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.
Mueller SN; Jones CM; Chen W; Kawaoka Y; Castrucci MR; Heath WR; Carbone FR
J Virol; 2003 Feb; 77(4):2445-51. PubMed ID: 12551982
[TBL] [Abstract][Full Text] [Related]
12. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells.
Treat BR; Bidula SM; Ramachandran S; St Leger AJ; Hendricks RL; Kinchington PR
PLoS Pathog; 2017 Dec; 13(12):e1006732. PubMed ID: 29206240
[TBL] [Abstract][Full Text] [Related]
13. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
15. Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation.
Toka FN; Gieryńska M; Suvas S; Schoenberger SP; Rouse BT
Virology; 2005 Jan; 331(1):151-8. PubMed ID: 15582662
[TBL] [Abstract][Full Text] [Related]
16. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response.
Bettahi I; Zhang X; Afifi RE; BenMohamed L
Viral Immunol; 2006; 19(2):220-36. PubMed ID: 16817765
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection.
Nass PH; Elkins KL; Weir JP
Vaccine; 2001 Jan; 19(11-12):1538-46. PubMed ID: 11163680
[TBL] [Abstract][Full Text] [Related]
20. Diminished secondary CTL response in draining lymph nodes on cutaneous challenge with herpes simplex virus.
Jones CM; Cose SC; McNally JM; Jennings SR; Heath WR; Carbone FR
J Gen Virol; 2000 Feb; 81(Pt 2):407-14. PubMed ID: 10644839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
